The EGFR is one of the most frequently overexpressed proteins in various cancers including lung cancer, and signalling through this receptor is related to tumour progression and resistance to most treatments (Rusch et al, 1993; Fontanini et al, 1998; Ciardiello and Tortora, 2008). Here, EGFR is linked to neoplasm.